The search for new cardiovascular biomarkers

Robert E. Gerszten and Thomas J. Wang
Additional contact information
Robert E. Gerszten: Massachusetts General Hospital
Thomas J. Wang: Massachusetts General Hospital, Center for Immunology and Inflammatory Diseases

Nature, 2008, vol. 451, issue 7181, 949-952

Abstract: Abstract Despite considerable advances in the treatment of cardiovascular disease, it remains the leading cause of death in developed countries. Assessment of classic cardiovascular risk factors — including high blood pressure, diabetes and smoking — has a central role in disease prevention. However, many individuals with coronary heart disease (a narrowing of the blood vessels that supply the heart) have only one, or none, of the classic risk factors. Thus, new biomarkers are needed to augment the information obtained from traditional indicators and to illuminate disease mechanisms.

Date: 2008
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature06802 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:451:y:2008:i:7181:d:10.1038_nature06802

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature06802

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().